Single-cell sequencing uncovers sensory neuron–mediated CGRP signaling as a driver of sarcoma progression
Proceedings of the National Academy of Sciences · 28.10.2025 · 122 (43)
DOI: 10.1073/pnas.2500161122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 21.10.2025. Verfasst von Sowmya Ramesh und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University, Baltimore, MD 21205. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Sensory Receptor Cells, Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NIAMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Bone pain is a presenting feature of bone cancers such as osteosarcoma (OS), relayed by skeletal-innervating peripheral afferent neurons. Potential functions of tumor-associated sensory neurons in bone cancers beyond pain sensation are unknown. To uncover neural regulatory functions, a chemical-genetic approach in mice with a knock-in allele for TrkA was used to functionally perturb sensory nerve innervation during OS growth and disease progression. TrkA inhibition in transgenic mice led to significant reductions in sarcoma-associated sensory innervation and vascularization, skewed tumor associated macrophage polarization, reduced tumor growth and metastasis, and prolonged overall survival. Single-cell transcriptomics revealed that sarcoma denervation was associated with phenotypic alterations in both OS tumor cells and cells within the tumor microenvironment, and with reduced calcitonin gene-related peptide (CGRP) and vascular endothelial growth factor (VEGF) signaling. Multimodal and multiomics analyses of human OS bone samples further implicated peripheral innervation and neurotrophin signaling in OS tumor biology. Next and in two parallel approaches to inhibit nerve ingrowth, we repurposed FDA-approved bupivacaine liposomes and separately blocked CGRP signaling using FDA-approved Rimegepant. Both strategies led to significant reductions in sarcoma growth, vascularity, and sarcoma-induced hyperalgesia. In sum, TrkA-expressing peripheral neurons positively regulate key aspects of OS progression and sensory neural inhibition disrupts CGRP signaling within the sarcoma microenvironment leading to significantly reduced tumor growth and improved survival. These data suggest that interventions to prevent pathological innervation of OS represent an adjunctive therapy to improve clinical outcomes and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University, Baltimore, MD 21205.
- Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21205.
- Department of Neuroscience, Center for Advanced Pain Studies, University of Texas at Dallas, Dallas, TX 75080.
- Department of Surgery, University of Texas Southwestern, Dallas, TX 75390.
- Department of Dermatology, University of Wisconsin-Madison, Madison, WI 53715.
- Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
ORCID-Profile: Sowmya Ramesh, Qizhi Qin, Sam Bae, Ankit Uniyal, Khadijah Mazhar, Monisha Mittal, Edward F McCarthy, Carol D Morris, Yun Guan, Theodore J Price, Aaron W James
Förderung
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NIAMS NIH HHS
- NINDS NIH HHS
- NIDCR NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- DOD | USA | MRDC | U.S. Army Medical Research Acquisition Activity (USAMRAA)
- Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)
Zitieren
APA
Ramesh, S., Qin, Q., Li, Z., Cherief, M., Zhong, L., Archer, M., Xing, X., Thottappillil, N., Balaji, D., Bae, S., Gomez-Salazar, M., Xu, M., Zhu, M., Uniyal, A., Chang, L., Mazhar, K., Mittal, M., Birbrair, A., McCarthy, E. F., …, & James, A. W. (2025). Single-cell sequencing uncovers sensory neuron–mediated CGRP signaling as a driver of sarcoma progression. Proceedings of the National Academy of Sciences, 122(43). https://doi.org/10.1073/pnas.2500161122
Vancouver
Ramesh S, Qin Q, Li Z, Cherief M, Zhong L, Archer M, et al. Single-cell sequencing uncovers sensory neuron–mediated CGRP signaling as a driver of sarcoma progression. Proceedings of the National Academy of Sciences. 2025;122(43). doi:10.1073/pnas.2500161122
BibTeX
@article{Ramesh2025,
author = {Ramesh, Sowmya and Qin, Qizhi and Li, Zhao and Cherief, Masnsen and Zhong, Lingke and Archer, Mary and Xing, Xin and Thottappillil, Neelima and Balaji, Devadutta and Bae, Sam and Gomez-Salazar, Mario and Xu, Mingxin and Zhu, Manyu and Uniyal, Ankit and Chang, Leslie and Mazhar, Khadijah and Mittal, Monisha and Birbrair, Alexander and McCarthy, Edward F and Morris, Carol D and Levi, Benjamin and Guan, Yun and Clemens, Thomas L and Price, Theodore J and James, Aaron W},
title = {Single-cell sequencing uncovers sensory neuron–mediated CGRP signaling as a driver of sarcoma progression},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {43},
doi = {10.1073/pnas.2500161122}
}
EUVIMED